Scientific programme
Abstract Topics:
- Biovigilance
- Hidden adverse effects of blood transfusion
- Haemovigilance in specific clinical situations
- Cost-effectiviness of Haemovigilance
- Various
Scientific Program Wednesday, February 25th 2009
| 15.30 – 16.00 | Opening Ceremony |
| 16.00 – 18.00 |
Plenary Session 1: Haemovigilance from a global perspective Chair: G. Grazzini (Italy), R. de Vries (The Netherlands) |
| 16.00 – 16.30 |
Transfusion medicine in the area of proteomics G. Liumbruno, Italy |
| 16.30 – 17.00 | Coffee / Teabreak |
| 17.00 – 17.30 |
Accountibility in the context of Haemovigilance in different countries J. Faber, Luxembourg |
| 17.30 – 18.00 |
Haemovigilance in developing countries N. Dhingra, Switzerland |
| 18.00 – 19.00 | Welcome Reception |
Scientific Program Thursday, February 26th 2009
| 09.00 – 12.15 |
Plenary Session 2: Blood transfusion and haemovigilance in Italy Chair: G. Aprili (Italy), M. Ripamonti (Italy) |
| 09.00 – 09.25 |
The Italian Blood System G. Grazzini (Italy) |
| 09.25 – 09.50 |
Pros & Cons of a hospital-based blood system V. De Angelis (Italy) |
| 09.50 – 10.15 |
Organization of the Italian Haemovigilance System S. Pupella (Italy) |
| 10.15 – 10.45 | Coffee / Teabreak |
| 10.45 – 11.10 |
Haemovigilance at the regional level: the experience of the Region of Piedmont G. Facco (Italy), M. Girotto (Italy) |
| 11.10 – 11.35 |
Vigilance of transfusion transmissible diseases including emerging infections C. Velati (Italy) |
| 11.35 - 12.00 |
Hospitaltransfusion committees: their role in haemovigilance G. D’Onofrio (Italy) |
| 12.00 - 12.25 |
Pathogen inactivated platelets and prevention of immunological adverse reactions P. Rebulla (Italy)) |
| 12.25 - 14.00 | Lunch |
| 14.00 - 17.00 |
Parallel Session 1: Biovigilance A. Nanni Costa (Italy) |
| 14.00 - 17.00 |
Parallel Session 2: Hidden adverse effects of blood transfusion Chair: A. Brand (The Netherlands), C. Velati (Italy) |
| 15.15 - 15.45 | Coffee / Teabreak |
Scientific Program Friday, February 27th 2009
| 09.00 - 12.00 |
Parallel Session 3: Haemovigilance in specific clinical situations Chair: C. Taylor (UK) |
| 09.00 - 12.00 |
Parallel Session 4: Cost-effectiveness of Haemovigilance Chair: P. Strengers (The Netherlands), G. Grazzini (Italy) |
| 10.15 - 10.45 | Coffee / Teabreak |
| 12.00 - 14.00 | Lunch |
| 14.00 - 16.45 |
Plenary Session 3: New projects and future directions Chair: J. Faber (Italy) |
| 14.00 - 14.25 |
Experiences with the first year of reporting SAR and SAE to the EU To be announced |
| 14.25 - 14.50 |
The EHN data base: establishment and first results D. Politis (Greece), P. Robillard (Canada) |
| 14.50 - 15.15 |
Donation Vigilance: The surveillance of adverse events related blood donors and blood donation process J. Jørgensen (Denmark) |
| 14.50 - 15.15 | Coffee / Teabreak |
| 15.45 - 16.10 |
Materio-vigilance R. Clayton (Belgium) |
| 16.10 - 16.35 |
Biovigilance in the USA To be announced |
| 16.35 – 16.45 |
The International Haemovigilance Network (IHN) R. de Vries ( The Netherlands) |
| 16.45 - 17.05 | Closing Ceremony |
Key Dates:
| 1 December 2008: | Deadline for abstract submission |
| 8 December 2008: | Abstract Notification Information |
